2269 — WuXi Biologics (Cayman) Cashflow Statement
0.000.00%
Last trade - 00:00- HK$144.73bn
- HK$136.95bn
- CNY21.79bn
Annual cashflow statement for WuXi Biologics (Cayman), fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | — |
| Source: | ARS | ARS | ARS | ARS | |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Net Income/Starting Line | 3,993 | 5,358 | 4,174 | 4,834 | — |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 270 | 943 | 1,003 | 839 | — |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1,313 | -1,560 | -1,679 | -1,893 | — |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 3,431 | 5,542 | 4,668 | 5,217 | — |
| Capital Expenditures | -6,523 | -5,868 | -4,221 | -3,930 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -3,079 | -39.9 | 992 | -12.1 | — |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -9,602 | -5,908 | -3,228 | -3,942 | — |
| Financing Cash Flow Items | -104 | 508 | 92.6 | -1,294 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 8,209 | -2,592 | 1,961 | -2,750 | — |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1,908 | -2,608 | 3,275 | -1,391 | — |